Norway's sovereign wealth fund to abstain from Novo Nordisk board vote

Core Viewpoint - Norway's sovereign wealth fund, the largest in the world, will abstain from voting on new board members, including the chair, at Novo Nordisk's extraordinary shareholders' meeting scheduled for November 14 [1] Group 1 - The decision to abstain from voting indicates a significant stance by Norway's sovereign wealth fund regarding corporate governance at Novo Nordisk [1] - The extraordinary shareholders' meeting is set for November 14, highlighting an upcoming critical event for Novo Nordisk [1]